FDA Info On Use of Medically Important Antimicrobials in Bees
Story Date: 12/20/2017

FDA Provides Information on the Use of Medically Important Antimicrobials in Bees

The FDA is announcing the availability of a Question and Answer document about the use of medically important antimicrobials in bees to provide helpful information to beekeepers and veterinarians. The Q&A titled “Using Medically Important Antimicrobials in Bees” responds to some commonly asked questions about the appropriate use of approved Veterinary Feed Directive (VFD) and prescription (Rx) drug products for bees.

In January 2017, the FDA and animal drug sponsors completed the voluntary process of transitioning medically important antimicrobial drugs used in animal feed or water from over-the–counter (OTC) marketing status to VFD or Rx marketing status under FDA’s Guidance for Industry (GFI) #213. This marked an important step forward in national efforts to address the use of medically important antimicrobials and promote antimicrobial stewardship in animals. Certain medically important antimicrobial drugs affected by this process are approved for use in bees. As a result, beekeepers have raised questions about how the changes affect them.

Questions not addressed in the Q&A document may be directed to AskCVM@fda.hhs.gov.

Contact FDA

240-402-7002
240-276-9115 FAX
Issued by: FDA, Center for Veterinary Medicine

7500 Standish Place, HFV-1

Rockville, MD 20855




NC Veterinary Medical Association
1611 Jones Franklin Road, Suite 108
Raleigh, NC 27606-3376
Tel: (800) 446-2862 / (919) 851-5850
Fax: (919) 851-5859
Email: ncvma96@ncvma.org